(Q59559680)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620642%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620642%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620642%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Paolo Livrea

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620642%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Maria Trojano

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620642%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Carlo Avolio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620642%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Maddalena Ruggieri

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620642%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Fabrizio Giuliani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620642%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Rosaria Leante

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620642%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Paolo Riccio

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620642%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620642%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620642%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620642%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620642%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

46-53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620642%20AND%20SRC:MED&resulttype=core&format=json

Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Matrix metalloproteinases in multiple sclerosis: targets of therapy or markers of injury?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Tissue inhibitors of metalloproteinases: evolution, structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Enhancement frequency decreases with increasing age in relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Matrix metalloproteinases in inflammatory demyelination: targets for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Monocyte-derived dendritic cells express and secrete matrix-degrading metalloproteinases and their inhibitors and are imbalanced in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Mechanisms of action of glatiramer acetate in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

T-cell- and macrophage-mediated axon damage in the absence of a CNS-specific immune response: involvement of metalloproteinases.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Metalloproteinases and their tissue inhibitors in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Matrix metalloproteinases in multiple sclerosis: is it time for a treatment trial?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Changes of serum sICAM-1 and MMP-9 induced by rIFN -1b treatment in relapsing-remitting MS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Differential mechanisms of action of interferon-beta and glatiramer aetate in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Metalloproteinases in biology and pathology of the nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900006-7

7 January 2021

10.1016/S0165-5728(03)00006-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620642%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference